8-K//Current report
Amylyx Pharmaceuticals, Inc. 8-K
Accession 0001193125-25-135860
$AMLXCIK 0001658551operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:04 PM ET
Size
143.5 KB
Accession
0001193125-25-135860
Documents
- 8-Kd920336d8k.htmPrimary
8-K
- EX-101.SCHamlx-20250605.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABamlx-20250605_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREamlx-20250605_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-135860-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd920336d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001658551
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:04 PM ET
- Size
- 143.5 KB